Top Story
Alps Global Holding Berhad enters final Nasdaq IPO phase with regulatory steps nearly complete, signaling a likely debut in coming weeks.

Policy & Government
Malaysia’s biotech sector gains international recognition, supported by national innovation policies and strategic investment goals.

Business & Economy
The US$100 million listing would mark Alps as a rare Malaysian biotech firm reaching global markets, with funding earmarked for precision medicine.Social Impact
Expected outcomes include expanded clinical trials, personalized health services, and stronger cross-border biotech ecosystems involving Malaysia.